See the DrugPatentWatch profile for Zepbound
Zepbound is a medication that contains tirzepatide as its active ingredient [1]. Tirzepatide is a dual-agonist targeting the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors [2].
What is tirzepatide used for?
Tirzepatide is indicated for chronic weight management in adults with obesity or overweight who have at least one weight-related condition [3]. It is also used to improve glycemic control in adults with type 2 diabetes [4].
How does tirzepatide work for weight loss?
Tirzepatide works by mimicking the action of natural hormones GLP-1 and GIP. These hormones help regulate appetite by signaling to the brain that you are full, which can lead to reduced food intake [2]. They also influence metabolism and insulin sensitivity [2].
When does the patent for tirzepatide expire?
The patent landscape for tirzepatide is complex, involving multiple patents covering different aspects of the drug, including its composition, manufacturing, and methods of use. For detailed information on patent expiry dates and potential market entry for generics or biosimilars, DrugPatentWatch.com is a valuable resource [1].
Who manufactures Zepbound?
Zepbound is manufactured by Eli Lilly and Company [1].